Roles of the DOCK-D family proteins in a mouse model of neuroinflammation.
DOCK10
DOCK11
DOCK9
astrocyte
gene knockout
guanine nucleotide exchange factor (GEF)
microglia
migration
neurodegeneration
Journal
The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R
Informations de publication
Date de publication:
08 05 2020
08 05 2020
Historique:
received:
01
08
2019
revised:
16
03
2020
pubmed:
4
4
2020
medline:
19
12
2020
entrez:
4
4
2020
Statut:
ppublish
Résumé
The DOCK-D (dedicator of cytokinesis D) family proteins are atypical guanine nucleotide exchange factors that regulate Rho GTPase activity. The family consists of Zizimin1 (DOCK9), Zizimin2 (DOCK11), and Zizimin3 (DOCK10). Functions of the DOCK-D family proteins are presently not well-explored, and the role of the DOCK-D family in neuroinflammation is unknown. In this study, we generated three mouse lines in which
Identifiants
pubmed: 32241915
pii: S0021-9258(17)48528-0
doi: 10.1074/jbc.RA119.010438
pmc: PMC7212640
doi:
Substances chimiques
Guanine Nucleotide Exchange Factors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
6710-6720Informations de copyright
© 2020 Namekata et al.
Références
Immunol Rev. 2012 Jul;248(1):170-87
pubmed: 22725961
Am J Pathol. 2017 Dec;187(12):2876-2885
pubmed: 28919108
J Cell Sci. 2012 Feb 15;125(Pt 4):858-68
pubmed: 22399802
J Neuroimmunol. 2018 May 15;318:1-7
pubmed: 29606295
Invest Ophthalmol Vis Sci. 2015 Dec;56(13):7687-90
pubmed: 26641546
Prog Retin Eye Res. 2014 Nov;43:1-16
pubmed: 25016980
Heliyon. 2019 Mar 23;5(3):e01391
pubmed: 30963125
Immun Ageing. 2012 Apr 11;9:2
pubmed: 22494997
Invest Ophthalmol Vis Sci. 2011 Apr 01;52(5):2696-703
pubmed: 21228387
Nat Rev Neurol. 2016 Sep;12(9):539-51
pubmed: 27514287
J Biol Chem. 2012 Aug 17;287(34):28632-45
pubmed: 22753414
Immunobiology. 2016 Dec;221(12):1343-1350
pubmed: 27502165
Immun Ageing. 2015 Feb 22;12:1
pubmed: 25729399
Mol Immunol. 2008 Jul;45(12):3411-8
pubmed: 18499258
Vision Res. 1999 Feb;39(3):419-36
pubmed: 10341974
Nat Commun. 2015 Jul 01;6:7286
pubmed: 26129894
Front Immunol. 2017 May 01;8:491
pubmed: 28507547
J Neurosci Res. 2009 Jun;87(8):1794-805
pubmed: 19156867
Biol Open. 2015 Apr 10;4(5):627-35
pubmed: 25862245
J Neuroimmunol. 2014 Sep 15;274(1-2):53-61
pubmed: 25005117
Eur J Immunol. 1995 Jul;25(7):1951-9
pubmed: 7621871
Int Immunol. 2017 Nov 1;29(9):431-438
pubmed: 29099971
Exp Neurobiol. 2016 Oct;25(5):262-268
pubmed: 27790060
FEBS Lett. 2005 Feb 14;579(5):1039-46
pubmed: 15710388
Nat Neurosci. 2012 Jul 26;15(8):1074-7
pubmed: 22837037
J Exp Med. 2017 Jan;214(1):209-226
pubmed: 28028151
Trends Cell Biol. 2007 Aug;17(8):383-93
pubmed: 17765544
Hum Immunol. 2011 Jul;72(7):531-7
pubmed: 21514340
Genes Dev. 2014 Mar 15;28(6):533-47
pubmed: 24637113
Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):E5883-90
pubmed: 26460013
Trends Cell Biol. 2005 Mar;15(3):163-71
pubmed: 15752980
Br J Pharmacol. 2011 Oct;164(4):1079-106
pubmed: 21371012
J Biol Chem. 2019 Sep 6;294(36):13421-13433
pubmed: 31337702
J Infect Dis. 1997 Feb;175(2):478-81
pubmed: 9203678
J Neurosci. 2011 Aug 31;31(35):12471-82
pubmed: 21880909
Acta Neuropathol. 2006 Aug;112(2):195-204
pubmed: 16733654
EMBO Mol Med. 2010 Dec;2(12):504-15
pubmed: 21064192
J Clin Invest. 2007 Jul;117(7):1763-70
pubmed: 17607354